ArticleFrontiers in pharmacology2020

Escitalopram Ameliorates Cardiomyopathy in Type 2 Diabetic Rats via Modulation of Receptor for Advanced Glycation End Products and Its Downstream Signaling Cascades.

Lamiaa A Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.